The global nuclear imaging equipment market size was valued at USD 2.8 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 5.62% during the forecast period of 2024-2032 to achieve a value of USD 4.5 billion by 2032.
Nuclear imaging equipment are used to envision and evaluate the body organs in a human body. The equipment are used to observe the structure and working functionality of specific organs or all the organs present in the human body. To perform these observations, the healthcare professionals make patients administer a radioactive substance, which is also known as radiopharmaceuticals. The radiations a person experience with the amount and type of the radioactive substance being administered is minimal. These radiopharmaceuticals are used to examine and evaluate the path of the substance after its administration. The observation is being done on a molecular level.
The continuous technological advancement in the field has been significantly aiding the nuclear imaging equipment market expansion. These technological advancements might include software updates and equipment modifications. The increasing investments on the research and development on finding new radiopharmaceuticals is also a key trend for the market. The discovery or innovation of new radiopharmaceuticals may help observe the functionality of organs in the patient that are suffering from cancer, as cancer imaging.
Market Breakup by Type
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases, among others, has been driving the growth of the market. The increasing prevalence of chronic diseases has been contributing to the nuclear imaging equipment market growth. To diagnose these chronic diseases, use of nuclear imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is conducted. The nuclear imaging equipment market is witnessing steady growth and is expected to keep growing for the forecast period as well owing to the rising demand for imaging and proper diagnosis for these life-threatening conditions. The rising investment and funding by the key players and the governments is anticipated to contribute significantly to the nuclear imaging equipment market development.
Additionally, factors like rising competition amongst the key players and the rapid development of equipment and devices is likely to bolster the growth of the market in the coming years.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Applications||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nuclear Imaging Equipment Market Overview
3.1 Global Nuclear Imaging Equipment Market Historical Value (2017-2023)
3.2 Global Nuclear Imaging Equipment Market Forecast Value (2024-2032)
4 Global Nuclear Imaging Equipment Market Landscape
4.1 Global Nuclear Imaging Equipment Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nuclear Imaging Equipment Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Nuclear Imaging Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nuclear Imaging Equipment Market Segmentation
6.1 Global Nuclear Imaging Equipment Market by Type
6.1.1 Market Overview
6.1.2 Gamma Camera Imaging Systems
18.104.22.168 SPECT Imaging Systems
22.214.171.124 Planar Scintigraphy Imaging Systems
6.1.3 PET Imaging Systems
6.2 Global Nuclear Imaging Equipment Market by Applications
6.2.1 Market Overview
6.2.8 Thyroid-Related Disorders
6.3 Global Nuclear Imaging Equipment Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Diagnostic Imaging Centers
6.3.4 Specialty Clinics
6.4 Global Nuclear Imaging Equipment Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Nuclear Imaging Equipment Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Nuclear Imaging Equipment Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Nuclear Imaging Equipment Market
9.1 Market Share by Country
10 Latin America Nuclear Imaging Equipment Market
10.1 Market Share by Country
11 Middle East and Africa Nuclear Imaging Equipment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Siemens Healthineers AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 GE Healthcare
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Koninklijke Philips N.V.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Canon Medical Systems Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Star Equity Holdings, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 SurgicEye GmbH
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Mediso Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Rigaku Corporation (MILabs B.V.)
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 MR Solutions Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 DDD - Diagnostics A/S
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Segami Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Mirion Technologies (Capintec), Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Positron Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 Neusoft Medical Systems Co., Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
18 Global Nuclear Imaging Equipment Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 2.8 billion in 2023, driven by the rapid technological advancements.
The market anticipated to grow at a CAGR of 5.62% during the forecast period of 2024-2032 and reach a market value of USD 4.5 billion by 2032.
The increasing prevalence of chronic diseases across the globe is a major driver for the nuclear imaging equipment market.
The increasing focus on finding new radioactive tracers in the diagnosis and treatment of disease is a key trend for the market.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The different types of nuclear imaging equipment in the market include gamma camera imaging systems and PET imaging systems.
Nuclear imaging equipment finds wide applications in oncology, cardiology, neurology, urology, orthopaedics, gastroenterology, and thyroid-related disorders, among others.
The end-users for nuclear imaging equipment include hospitals and clinics, diagnostic imaging centres, and specialty clinics, among others.
Key players involved in the market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Star Equity Holdings, Inc., SurgicEye GmbH, Mediso Ltd., Rigaku Corporation (MILabs B.V.), MR Solutions Ltd., DDD - Diagnostics A/S, Segami Corporation, Mirion Technologies (Capintec), Inc., Positron Corporation, Neusoft Medical Systems Co., Ltd., and Canon Medical Systems Corporation.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.